The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 29, 2014

Filed:

Oct. 07, 2011
Applicants:

Marina D'angelo, Philadelphia, PA (US);

Abdulhafez Selim, Long Beach, NJ (US);

Inventors:

Marina D'Angelo, Philadelphia, PA (US);

Abdulhafez Selim, Long Beach, NJ (US);

Assignee:

ProteaPex Therapeutics LLC, Philadelphia, PA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/48 (2006.01); A61K 38/55 (2006.01); C07K 14/81 (2006.01); A61K 38/00 (2006.01); A61K 38/18 (2006.01); C07K 14/495 (2006.01); A61P 19/02 (2006.01); A61P 19/00 (2006.01); C07K 2/00 (2006.01); C07K 4/00 (2006.01); C07K 5/00 (2006.01); C07K 7/00 (2006.01); C07K 14/00 (2006.01); C07K 16/00 (2006.01); C07K 17/00 (2006.01); A61K 38/04 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention provides compounds for disrupting the binding of a matrix metalloprotease (MMP) protein to a substrate protein at an interaction site other than the protease catalytic site. In particular the inventive compounds inhibit the MMP's ability to cleave a substrate protein. In some cases the compound may prevent activation of transforming growth factor beta (TGFβ). The compounds are preferably polypeptide fragments of the hemopexin-like domain of the MMP, but may be mimetics thereof or peptides or mimetics of the portion of the MMP substrate protein to which the MMP interacts.


Find Patent Forward Citations

Loading…